Danbury, CT, United States of America

Xuan Jiang

This inventor holds 1 USPTO granted patent. Top assignee: Perosphere Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xuan Jiang. Retrieved from https://idiyas.com/inventor/xuan-jiang-k1uo34fm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xuan Jiang: Innovator in Stable Glucagon Formulations

Introduction

Xuan Jiang is a notable inventor based in Danbury, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable glucagon formulations. His innovative work aims to enhance the stability and efficacy of peptide-based medications.

Latest Patents

Xuan Jiang holds a patent for "Stable glucagon formulations." This patent describes stabilized formulations containing peptides, such as glucagon, which are presented in the form of solutions or suspensions. These formulations exhibit minimal chemical degradation and aggregation of the peptide over extended periods. The solutions may include a solvent like glycerin and thermal stabilizers, while the suspensions contain nano- and/or microparticles of the peptide suspended in a non-aqueous medium. The innovative approach of micronizing the peptide with humectants enhances the dissolution rate upon administration.

Career Highlights

Xuan Jiang is currently associated with Perosphere Inc., where he continues to advance his research and development efforts. His work is pivotal in creating formulations that improve patient outcomes in glucagon administration.

Collaborations

Xuan collaborates with talented professionals such as Sasha Bakhru and Bryan Laulicht, contributing to a dynamic research environment that fosters innovation.

Conclusion

Xuan Jiang's contributions to stable glucagon formulations represent a significant advancement in pharmaceutical science. His innovative approach and dedication to improving peptide stability are commendable and have the potential to impact patient care positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…